BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order

Reuters05-12

Updates

** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%

** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay

** White House officials say government will give drugmakers price targets in next 30 days

** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5%

** "While we believe an executive order is a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view," brokerage UBS says

** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2534277772?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-12 22:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2534277772","market":"us","top_or_hot":-1,"title":"BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order</title></head><body>Updates** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay** White House officials say government will give drugmakers price targets in next 30 days ** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5% \n** \"While we believe an executive order is a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view,\" brokerage UBS says\n** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com))</body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nReuters \n2025-05-12 22:46\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order</title></head><body>Updates** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay** White House officials say government will give drugmakers price targets in next 30 days ** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5% \n** \"While we believe an executive order is a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view,\" brokerage UBS says\n** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com))</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0640476718.USD","symbol_name":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL4N3RK19G:1","article_id":"2534277772","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2534277772","pubTimestamp":1747061177,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive orderUpdates** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay** White House officials say government will give drugmakers price targets in next 30 days ** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5%. ** \"While we believe an executive orderis a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view,\" brokerage UBS says. ** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","SG9999001176.USD":"United Global Healthcare Acc USD","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","AMGN":"安进","BK4007":"制药","BMY":"施贵宝","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK4599":"减肥药","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0354030511.USD":"ALLSPRING U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","LU2471134879.HKD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (HKD) INC","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","BK4516":"特朗普概念","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","SG9999014542.SGD":"United Income Focus Trust Acc SGD","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","SG9999014567.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","SG9999014880.SGD":"大华全球优质成长基金Acc SGD","GILD":"吉利德科学","LU1035773651.USD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (USD) INC","LU0203202063.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A2X\" (USD) ACC","PFE":"辉瑞","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","BK4139":"生物科技","MRK":"默沙东"},"translate_title":"特朗普计划在行政命令中广泛降低药品价格，美国制药商股价上涨","themeId":"d1f20c50ccff9e2728348a7194f9efd9","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":0.9,"PFE":0.9,"AMGN":0.9,"GILD":0.9,"BMY":0.9},"content_text":"BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive orderUpdates** Shares of U.S. drugmakers reverse course, rise between 1.5% and 5%** President Donald Trump plans to sign wide-reaching executive order directing drugmakers to lower prices of medicines to align with what other countries pay** White House officials say government will give drugmakers price targets in next 30 days ** Shares of Bristol Myers Squibb BMY.N up 1.5%, Merck MRK.N up 4.1%, Amgen AMGN.N up 1.9%, Gilead GILD.O up 4.9% and Pfizer PFE.N up 2.5% \n** \"While we believe an executive order is a quicker route for Trump to implement, this will be challenged by Biopharma, which could take months to a year to play out, in our view,\" brokerage UBS says\n** Including session moves, LLY down 5.1%, BMY down 15.9%, MRK down 20.6%, AMGN up 4.9%, GILD up 9.8% and PFE down 14% YTD (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2534277772","isCrawlerRequest":true}